First Canadian clinical trials for COVID-19 vaccine to be led by Dalhousie University researchers

The Canadian Centre for Vaccinology will soon begin testing the potential vaccine to see how well it is tolerated by both younger and older adults.
By: Alison Larabie Chase
May 20, 2020
Photo: Danny Abriel

With several potential vaccines for COVID-19 being researched across Canada, the first to enter clinical (human) trials will happen at the Canadian Centre for Vaccinology, located at Dalhousie University in Halifax, N.S. The team there is building on research conducted by its Chinese partner CanSino Biologics, which is already conducting clinical trials in China.

The first phases of testing will begin within a few weeks and will closely monitor both younger and older adults to see how well their bodies tolerate the prospective vaccine. Once those trials are complete, the next testing phase will determine the effectiveness of the vaccine at preventing COVID-19 infection.

Generally, the process of creating vaccines takes years, but the Canadian government might permit a vaccine that has been shown to be safe and effective to be released early, due to the emergency nature of the COVID-19 pandemic. If it does work, the National Research Council will help the vaccine’s makers to produce and distribute it here in Canada.

Source: Dalhousie University



2 months ago

U of T researchers developing a rapid COVID-19 antibody test

The new test will be able to determine if a person has been infected with SARS-CoV-2 and developed antibodies to it in less than an hour.
2 months ago

Saskatchewan laboratory and National Research Council team up to increase production of potential COVID-19 vaccine

The lab at the University of Saskatchewan hopes the assistance from the NRC will allow them to make more of the candidate vaccine they are studying and produce it more quickly for testing.